Table 1.
Effects of WSS magnitude on angiogenic events and signaling. Experiments were performed using HUVECs unless otherwise stated.
<2 dyn/cm2 | 3–8 dyn/cm2 | >10 dyn/cm2 | References | |
---|---|---|---|---|
| ||||
3-D invasion assay | ||||
invasion density | ↓ | ↑ | ↓ | (54) |
invasion depth | ↑ | ↑ | (54) | |
| ||||
2-D Matrigel tubule formation assay | ↑ | ↑ ↑ | ↑ ↑ ↑ | (22) |
| ||||
Transwell cell migration rate | - | ↑ | ↑ ↑ | (22) |
| ||||
Ang-2 expression | ↑ | ↓ | ↓ | (40) |
↓ | (19)* | |||
| ||||
TIE-2 expression | ↑ | ↑ | (19)* | |
- | ↑ | ↑ | (40) | |
| ||||
VEGF-A expression (in skeletal muscle microvascular EC) | ↑ | ↑ ↑ | (40) | |
↑ | (71)* | |||
| ||||
Ephrin-B2 expression | ↑ | ↓ | ↓ | (39) |
Ephrin-B2 expression (in VEGFR+ ESC) | ↑ | ↑ | (70) | |
Ephrin-B4 expression (in VEGFR+ ESC) | ↓ | (70) | ||
| ||||
Notch | ↑ | (111) | ||
Notch1 and Notch 4 expression (in VEGFR2+ ESC) | ↓ | ↑ | (70) | |
| ||||
Akt Phosphorylation | ↓ | ↑ | ↓ | (54) |
↑ | (19)* | |||
↑ | ↑ ↑ | (29) | ||
| ||||
eNOS phosphorylation | ↑ | (29) | ||
| ||||
HIF-1α, HIF-2α expression (in skeletal muscle microvascular EC) | ↓ | (71)* | ||
| ||||
Foxo-1 binding activity | - | ↓ | (40) | |
Foxo-1 expression | ↓ | (19)* | ||
Foxo-1 phosphorylation and nuclear exclusion | ↑ | (19)* | ||
| ||||
MMP-2 secretion | ↓ | ↑ | ↓ | (54) |
- | ↓ | (72) | ||
↓ | (116) | |||
↑ | (99)* | |||
| ||||
MMP-9 secretion | ↑ | (100)* | ||
↑ | (99)* | |||
| ||||
ADAMTS1 expression | - | ↑ | ↑ ↑ | (48) |
vs. static condition